Exemestane pharmacokinetics and estrogen suppression in young males
Demonstrated substantial estradiol suppression and testosterone increase.
Short-term and not designed for AAS users.
Original source ↗Loading TrenasCycles…
TrenasCycles
Loading TrenasCycles…
Ancillary / aromatase inhibitor
Aromasin
Exemestane lowers estrogen and is discussed as another option for managing high estrogen on cycle. Unlike anastrozole, it permanently switches off the aromatase enzyme it binds. Too much estrogen suppression can cause joint pain, fatigue, hot flashes and bone loss.
AROMASIN breast-cancer treatment in postmenopausal women. The label's food instruction matters; this is not a male hormone-control or bodybuilding regimen.
A controlled study in young men demonstrated estradiol suppression and reciprocal testosterone rise, but not long-term harm-reduction benefit.
Low estradiol, bone loss, joint symptoms, fatigue, lipid changes and drug interactions.
Estradiol and symptoms in clinical context; bone health and lipids with prolonged suppression.
Approved for selected breast-cancer indications; male and AAS-related use is off-label.
Demonstrated substantial estradiol suppression and testosterone increase.
Short-term and not designed for AAS users.
Original source ↗